Mr. Honjo of the Nobel Prize Taxes on the patent fee for refusal to receive The National Tax Agency September 10 13:34
Mr. Honjo, who won the Nobel Prize in Medicine and Physiology, refused to receive a drug from a pharmaceutical company over a cancer drug that was involved in the development. Has determined that he should pay the tax and pointed out the omission of the declaration, it was revealed by interviews with the people concerned.
Yusuke Honjo, a special professor at Kyoto University, developed the cancer treatment drug Opdivo in collaboration with Osaka-based pharmaceutical company Ono Pharmaceutical Co., Ltd., and signed a contract to pay a patent fee in 2006 during development. ..
According to Mr. Honjo and the people involved, Mr. Honjo refused to accept the patent because the fee for using the patent was too low, and Ono Yakuhin Kogyo had deposited the rejected item in the form of "deposit" in the Legal Affairs Bureau. ..
About this, the Osaka National Tax Bureau refused to receive it, but it was paid under the contract, and Mr. Honjo said that it was necessary to pay income tax, the patent usage fee for 4 years until the adult was about 2.2 billion yen It means that the omission of the declaration was pointed out.
The amount of additional tax is about 700 million yen including the underreported additional tax.According to the person concerned on the side of Honjo, the additional tax will not be exempted even if the deposit is left without receiving it, and the deposit will increase further in the future. This means that I received the full amount, filed an amended tax return, and paid the tax.
Mr. Honjo said, “I basically consulted with a lawyer or a tax accountant and have already dealt with it according to the law. Since it is a private matter, I will not comment further.”